Condition
RSV Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 7 RSV Infection clinical trials that are recruiting, at sites in 7 countries (most in United States (3), France (2), Argentina (1)). By phase: Phase 2 (2), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 7Countries
Newest RSV Infection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Zelicapavir for RSV infection in young children | Phase 2 | Bangkok and 7 other locations | Recruiting | Mar 19, 2026 |
| Preventing RSV in infants born in France during the 2024–2025 season | — | Paris | Recruiting | Mar 18, 2025 |
| Revaccination with RSV vaccine during subsequent pregnancies | Phase 3 | Birmingham, Alabama and 96 other locations | Recruiting | Mar 10, 2025 |
| Revaccination with SCB-1019T vaccine in older adults | Phase 1 | Phoenix, Arizona and 4 other locations | Recruiting | Feb 24, 2025 |
| Vaccination against RSV in patients with weakened immune systems | Phase 2 | Vienna | Recruiting | Sep 19, 2024 |
| Evaluating the effectiveness of RSV vaccines in real-world settings | — | New Haven, Connecticut | Recruiting | Dec 15, 2023 |
| Measuring how RSV affects young children seen in clinics and hospitals | — | Créteil | Recruiting | Feb 8, 2021 |
All recruiting trials (7)
-
Zelicapavir for RSV infection in young children
This study tests whether Zelicapavir can help treat RSV infection in children aged 28 days to 36 months who are showing symptoms.
-
Preventing RSV in infants born in France during the 2024–2025 season
This questionnaire will see if infants born in metropolitan France between October 1, 2024 and January 31, 2025 are reached by and receive new RSV prevention measures such as nirsevimab or vaccines.
-
Revaccination with RSV vaccine during subsequent pregnancies
This study is testing if giving a second dose of the RSV vaccine to pregnant women who already had it is safe and effective for them and their babies.
-
Revaccination with SCB-1019T vaccine in older adults
This study is testing a new vaccine called SCB-1019T to see if it can boost immunity in healthy adults aged 60-85 who have already received the AREXVY vaccine.
-
Vaccination against RSV in patients with weakened immune systems
This study tests if giving two doses of the RSV vaccine to patients with weakened immune systems helps them better fight off RSV infections compared to the standard one dose given to healthy older adults.
-
Evaluating the effectiveness of RSV vaccines in real-world settings
This study is testing how well RSV vaccines work in the real world for infants who get respiratory illnesses.
-
Measuring how RSV affects young children seen in clinics and hospitals
This project will test adding lab tests for RSV, flu, and COVID-19 for children under 2 who come to clinics or hospitals with ear infections or bronchiolitis to see how often RSV causes their illness.
Related topics
Quick answers
How many RSV Infection clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (3 trials), France (2 trials), Argentina (1 trial), South Africa (1 trial), The Gambia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.